JOSEPH ODIN: Open Payments
NPI 1124058631 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$18,099 in 8 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $18,099
Consulting: $18,039Food & beverage: $60
| Company | Payments | Amount |
|---|---|---|
| Tanabe Pharma America, Inc. | 1 | $13,920 |
| Intercept Pharmaceuticals, Inc. | 4 | $3,309 |
| Gilead Sciences, Inc. | 3 | $870 |
Products named: OCALIVA, Epclusa.
Industry payments across NY — which companies pay providers there.
